Mexico city / /
The remdesivir, a treatment developed by the pharmaceutical company Gilead to treat patients of coronavirus covid-19, received the approval of the Food and Drug Administration of the united States (FDA), the president announced Donald Trump.
“I am pleased to announce that Gilead gained FDA authorization urgent for the use of the remdesivir,” said Trump at the White House
The drug it was approved after a study in patients infected by covid-19 they recovered faster, something that was announced by the director of the National Institute of Allergy and Infectious Diseases of the united States, Anthony Fauci. The FDA approval allows the drug to market without comprehensive data on its safety and effectiveness.
During a meeting with the chairman and ceo of Gilead, Daniel O’day, it described the measure as an important first step and said the company was donating 1 million bottles medication to help the patients.
What is the remdesivir?
The remdesivir is an antiviral drug designed initially for the Ebola virusthat though it didn’t help for this disease, and had not yet been approved in any site, has been promising in the treatment of patients infected by the coronavirus in China, according to doctors, and has been used to help cure some patients in the united States and France.
The company that is in charge of this medicine, Gilead Scienceshas launched the last phase of clinical trials in Asia and in the united States known as phase 3, in which the results have been positive, because patients with the covid-19 treated with this drug were recovered 31 percent faster others were given a placebo.
The journal The New York Times reported on Wednesday that the FDA had planned to issue an authorization to allow the emergency use of the drug remdesivir, developed by the pharmaceutical company Gilead, to treat the covid-19 after the announcement of Fauci on the results of the medication.